TD Private Client Wealth’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,132
Closed -$110K 1252
2023
Q3
$110K Sell
40,132
-1
-0% -$3 ﹤0.01% 631
2023
Q2
$126K Hold
40,133
0.01% 625
2023
Q1
$111K Buy
+40,133
New +$111K 0.01% 635